Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
T420066-5mg | 5mg | In stock | $216.90 | |
T420066-25mg | 25mg | In stock | $672.90 | |
T420066-50mg | 50mg | In stock | $1,088.90 | |
T420066-100mg | 100mg | In stock | $1,731.90 |
Synonyms | HY-17623 | 7-[[(4S)-5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-yl]oxy]-N,N,2-trimethyl-1H-benzimidazole-5-carboxamide | E83739 | GTPL12008 | Emixustat HCl | AS-84160 | EX-A4304 | Tegoprazan | doi:10.14272/QCZZSANNLWPGEA-UHFFFAOYSA-N.1 | LXI-15028 | TEGOPR |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of ATP4A |
Product Description | Biological activity Tegoprazan (CJ-12420, IN-A001, K-CAB, LXI-15028, RQ-00000004) is a novel potent and highly selective inhibitor of gastric H+/K+-ATPase with IC50s ranging from 0.29 μM to 0.52 μM for porcine, canine, and human H+/K+-ATPases in vitro, respectively. |
ALogP | 3.2 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide |
---|---|
INCHI | InChI=1S/C20H19F2N3O3/c1-10-23-14-6-11(20(26)25(2)3)7-17(19(14)24-10)28-15-4-5-27-16-9-12(21)8-13(22)18(15)16/h6-9,15H,4-5H2,1-3H3,(H,23,24)/t15-/m0/s1 |
InChi Key | CLIQCDHNPDMGSL-HNNXBMFYSA-N |
Canonical SMILES | CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C |
Isomeric SMILES | CC1=NC2=C(N1)C=C(C=C2O[C@H]3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C |
PubChem CID | 23582846 |
Molecular Weight | 387.38 |
PubChem CID | 23582846 |
---|---|
CAS Registry No. | 942195-55-3 |
ChEMBL Ligand | CHEMBL4297583 |
RCSB PDB Ligand | 8BN |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J2214382 | Certificate of Analysis | Jun 07, 2022 | T420066 |
J2214383 | Certificate of Analysis | Jun 07, 2022 | T420066 |
J2214429 | Certificate of Analysis | Jun 07, 2022 | T420066 |
J2214430 | Certificate of Analysis | Jun 07, 2022 | T420066 |
Solubility | Solubility (25°C): 77 mg/mL(198.77 mM)in DMSO;Insoluble in water; 77 mg/mL in Ethanol |
---|
1. Takahashi N, Take Y. (2018) Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility.. J Pharmacol Exp Ther, 364 (2): (275-286). [PMID:29180359] [10.1021/op500134e] |